These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7548749)

  • 41. Influence of valproic acid on the expression of various acyl-CoA dehydrogenases in rats.
    Kibayashi M; Nagao M; Chiba S
    Pediatr Int; 1999 Feb; 41(1):52-60. PubMed ID: 10200137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dysregulations of UDP-glucuronosyltransferases in rats with valproic acid and high fat diet induced fatty liver.
    Zhang L; Chu X; Wang H; Xie H; Guo C; Cao L; Zhou X; Wang G; Hao H
    Eur J Pharmacol; 2013 Dec; 721(1-3):277-85. PubMed ID: 24056123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of valproic acid on glycine conjugation of benzoic acid.
    Gregus Z; Fekete T; Varga F; Klaassen CD
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1068-75. PubMed ID: 8263766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pyruvate uptake is inhibited by valproic acid and metabolites in mitochondrial membranes.
    Aires CC; Soveral G; Luís PB; ten Brink HJ; de Almeida IT; Duran M; Wanders RJ; Silva MF
    FEBS Lett; 2008 Oct; 582(23-24):3359-66. PubMed ID: 18775709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined effects of a high-fat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats.
    Zhang LF; Liu LS; Chu XM; Xie H; Cao LJ; Guo C; A JY; Cao B; Li MJ; Wang GJ; Hao HP
    Acta Pharmacol Sin; 2014 Mar; 35(3):363-72. PubMed ID: 24442146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of valproic acid on hepatic and plasma levels of 15-F2t-isoprostane in rats.
    Tong V; Chang TK; Chen J; Abbott FS
    Free Radic Biol Med; 2003 Jun; 34(11):1435-46. PubMed ID: 12757854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new approach on valproic acid induced hepatotoxicity: involvement of lysosomal membrane leakiness and cellular proteolysis.
    Pourahmad J; Eskandari MR; Kaghazi A; Shaki F; Shahraki J; Fard JK
    Toxicol In Vitro; 2012 Jun; 26(4):545-51. PubMed ID: 22342442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-dependent pharmacokinetics of toxic metabolites is not related to increased toxicity following high-dose valproic acid in rats.
    Jung BH; Kim BJ; Lee MS; Lee JH; Oh JH; Lee YJ
    J Appl Toxicol; 2010 Nov; 30(8):775-8. PubMed ID: 21157986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.
    Zhao M; Zhang T; Li G; Qiu F; Sun Y; Zhao L
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):138-143. PubMed ID: 28273397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytochrome P-450-catalyzed desaturation of valproic acid in vitro. Species differences, induction effects, and mechanistic studies.
    Rettie AE; Boberg M; Rettenmeier AW; Baillie TA
    J Biol Chem; 1988 Sep; 263(27):13733-8. PubMed ID: 3138238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolism of valproate to hepatotoxic intermediates.
    Baillie TA
    Pharm Weekbl Sci; 1992 Jun; 14(3A):122-5. PubMed ID: 1502011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene expression profiles of murine fatty liver induced by the administration of valproic acid.
    Lee MH; Hong I; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
    Toxicol Appl Pharmacol; 2007 Apr; 220(1):45-59. PubMed ID: 17292431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic activation of valproic acid and drug-mediated hepatotoxicity. Role of the terminal olefin, 2-n-propyl-4-pentenoic acid.
    Baillie TA
    Chem Res Toxicol; 1988; 1(4):195-9. PubMed ID: 2979731
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of vitamin B6 on lens antioxidant system in valproic acid-administered rats.
    Tunali S
    Hum Exp Toxicol; 2014 Jun; 33(6):623-8. PubMed ID: 24107455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gas chromatography/negative ion chemical ionization mass spectrometry and liquid chromatography/electrospray ionization tandem mass spectrometry quantitative profiling of N-acetylcysteine conjugates of valproic acid in urine: application in drug metabolism studies in humans.
    Gopaul SV; Farrell K; Abbott FS
    J Mass Spectrom; 2000 Jun; 35(6):698-704. PubMed ID: 10862121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of mitochondrial fatty acid oxidation in pentenoic acid-induced fatty liver. A possible model for Reye's syndrome.
    Thayer WS
    Biochem Pharmacol; 1984 Apr; 33(8):1187-94. PubMed ID: 6712730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [An experimental study on hepatotoxicity of topiramate in young rats].
    Huang J; Ren RN; Chen XM; Ye LY
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):54-8. PubMed ID: 17306079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of valproate dose on formation of hepatotoxic metabolites.
    Anderson GD; Acheampong AA; Wilensky AJ; Levy RH
    Epilepsia; 1992; 33(4):736-42. PubMed ID: 1628592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. III. Influence of fasting.
    Löscher W; Wahnschaffe U; Hönack D; Drews E; Nau H
    Epilepsy Res; 1993 Dec; 16(3):183-94. PubMed ID: 8119269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA.
    Gopaul S; Farrell K; Abbott F
    Epilepsia; 2003 Mar; 44(3):322-8. PubMed ID: 12614387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.